MIM 2024

In April 2024, the Multiply project presented two important research posters at the 8th Pan-African Malaria Conference organized by the Multilateral Initiative on Malaria (MiM) in Kigali, Rwanda. This conference, held from the 21st to the 27th, brought together malaria scientists from across the continent to share research and discuss strategies to combat malaria in Africa. The following posters showcased the long-term impact of malaria chemoprevention efforts in Sierra Leone:

1. Coverage of Perennial Malaria Chemoprevention with Sulfadoxine-Pyrimethamine and Prevalence of Malaria in Young Children Four Years After Implementation in Sierra Leone: This study provides insights into the effectiveness and reach of sustained malaria chemoprevention efforts among young children, assessing both coverage rates and the ongoing prevalence of malaria.
2. Prevalence of Plasmodium falciparum Molecular Markers of Resistance to Sulfadoxine-Pyrimethamine Four Years into Perennial Malaria Chemoprevention Implementation in Sierra Leone: This research evaluates resistance markers in Plasmodium falciparum, focusing on the adaptability of the malaria parasite to prevention methods over time, which is critical for informing future treatment strategies.

Through these presentations, the Multiply project contributed valuable findings to the understanding of malaria chemoprevention efficacy and resistance patterns, fostering dialogue among malaria experts on the best approaches to reduce malaria incidence in high-risk populations.

Additionally, ISGlobal and CISM led a symposium titled “Integrating Chemoprevention Strategies to End Malaria.” This symposium brought together leading malaria scientists to discuss innovative strategies for malaria prevention and elimination across sub-Saharan Africa.

As part of the symposium, Dr. Fombah delivered a presentation on “Implementing Perennial Malaria Chemoprevention (PMC) in Sub-Saharan Africa: Lessons Learned from the National Scale-up in Sierra Leone,” highlighting key insights from Multiply’s involvement in the PMC initiative. This presentation provided a valuable case study on the challenges, successes, and practical considerations of scaling up malaria chemoprevention at the national level, offering evidence-based lessons to inform similar efforts across the region.